MBT-2 - Syngeneic Model
Rincon Bio performs MBT-2 syngeneic models to test efficacy of immunotherapies. Please see below for additional information or to request a quote.
Organism: Mus musculus, mouse Breed/subspecies: C3H/He / Tissue: Bladder / Disease: Transitional Cell Carcinoma
Mouse Bladder Tumor line-2
Used as a syngeneic model. Implanted tumor cells create a model in which to test the efficacy of novel immunotherapies
Rincon Bio Growth Curve
Cell Line: MBT2
Mouse Strain: CH3
Positive Control: Anti-PD1
Concentration: 2.5 & 5 mg/kg
Tumor target size for stratification: 50 mm^3
From implant to stratification: 10 days
Cells Implanted per Animal: 5x10^5
WHY WORK WITH
When you work with Rincon Bio, rest assured that all cancer efficacy studies will be performed in the USA, at competitive prices
Most efficacy studies can be initiated within two business days.
We love our clients! We take a personal interest in our clients and their studies.